| Name | Title | Contact Details |
|---|---|---|
Robert Voreyer |
Chief Financial Officer | Profile |
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
OUR MISSION: We believe that wellness is a pursuit and that nature has the ability to empower our health now and in the future.. It is our mission to provide the safest, highest quality cannabis-based products that empower your health and enable you and your loved ones to live well. OUR STORY: This past decade has seen a powerful shift in the way we define healthy living. From greater access to naturally-grown, organic foods to the awareness of the dangers in overly-processed, chemically-dependent products, communities everywhere are rediscovering what it means to live well. Surterra Wellness believes that this push for safe, natural ingredients should not stop at the grocery store, and we are focused on transforming the way people take control of their health. Founded in 2014, Surterra Wellness is focused on unlocking the natural health benefits of the cannabis-based ingredients and is committed to providing individuals with the safest, most effective treatments. By combining natural growing techniques with innovative extraction tools, Surterra Wellness is looking to transform the way people view nature-based wellness solutions. Today, Surterra Wellness is bringing together leaders focused on patient health and safety. Together we are utilizing best practices in medicine, science and agriculture to discover and advance the natural healing benefits of cannabis-based products. Naturally-derived and uniquely formulated, these health-based solutions are empowering people throughout our communities to relieve their symptoms and to restore their own health in the safest, most effective way possible. Together, we are in pursuit of wellness.
American Viatical Svc is a Woodstock, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Story County Medical Center is full-service, primary-care medical center dedicated to providing you high quality healthcare in a community-oriented manner. We value personal service, open communications, a team approach to your care and the relationships built along the way.
USAID is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.